Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of ...

Twenty-seven states and the District of Columbia have filed a lawsuit in bankruptcy court seeking to block the sale of ...

Once a Silicon Valley pioneer in consumer genetic testing, 23andMe is now at the center of a high-stakes legal and financial ...

To help our clients and readers sort through the volume of privacy, cyber, and AI news, we are switching Privacy, Cyber, & AI ...

Me is teetering on the edge of bankruptcy and actively seeking a buyer. That buyer, unless explicitly restricted, could gain ...

Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.

On 23 March 2025, the direct-to-consumer genetic testing company 23andMe filed a voluntary Chapter 11 petition in a US bankruptcy court.1 The objective of this bankruptcy is to sell the company ...

Amy Klobuchar are rolling out a bipartisan measure to protect sensitive genetic data ... for 23andMe was part of the Chapter 11 bankruptcy protection it filed in March to arrange a sale of its ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of a law professor. In a report due before June 10, he’ll recommend to the ...

In other words, the pharmaceutical company is capable of providing similar services that 23andMe once did for its customers. It also plans to use the acquired data to inform drug development.

Regeneron Pharmaceuticals Inc. REGN announced Monday that it has secured the winning bid in the bankruptcy auction for key assets of 23andMe Holding ... s focus on ethical data use and scientific ...